Immunai vs Pomicell

Immunai vs Pomicell, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immunai is on 69/100 and Pomicell on 46/100.

Immunai logo
ImmunaiMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
Try Immunai
Pomicell logo
PomicellIntegrates scientific big data with patient medical records for personalized disease models and AI-driven insights.
Try Pomicell

Where each one leads

Immunai

  • our overall score: 69/100 against 46/100
  • agent readiness: 32/100 against 21/100
  • domain rating: 46/100 against 4/100
  • headcount: 179 against 5
  • headcount growth: +13.0% against -29.7%
  • funding raised: $295M against $300K
  • LinkedIn following: 26,832 against 2,777

Pomicell

Leads on none of the measures we hold for both companies.

At a glance

MeasureImmunaiPomicell
What it isMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.
CategoryHealthcare, Immunology, Data, AnalyticsHealthcare, Biotech, Decision Support, Analytics
Sells toBusiness modelB2BB2B
OfferingSoftwareSoftware
Founded20192016
HeadquartersNew York, United StatesJerusalem, Israel
StatusActiveInactive

Size, funding and growth

MeasureImmunaiPomicell
Employees1795
Headcount growthLast 12 months+13.0%-29.7%
Total funding$295M$300K
Latest roundSeries BSeed
Valuation$1.0BNot published
LinkedIn followers26,8322,777

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureImmunaiPomicell
StartupHub scoreOur 0-100 rating69/10046/100
Traction60/10035/100
Team70/10050/100
Search visibility39/10036/100
Quality78/10052/100
Agent readinessHow well an AI agent can read and act on the siteF (32/100)F (21/100)
Domain ratingLink authority, 0-10046/1004/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureImmunaiPomicell
CMSWordPressWix
FrameworksJquery, BootstrapNot detected
AnalyticsGoogle Tag ManagerNot detected

Immunai vs Pomicell: common questions

Which is better, Immunai or Pomicell?

On our 0-100 score Immunai rates higher (69/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.

How do Immunai and Pomicell compare on the numbers?

Immunai leads on our overall score (69/100 against 46/100), agent readiness (32/100 against 21/100), domain rating (46/100 against 4/100), headcount (179 against 5), headcount growth (+13.0% against -29.7%), funding raised ($295M against $300K), LinkedIn following (26,832 against 2,777).

Read the full Immunai review and pricing or the Pomicell review and pricing. You can also browse other Immunai alternatives we track.